Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 11, 2014, Pages 1905-1910

  Ananthakrishnan, Ashwin N ^a,b   Cagan, Andrew ^c   Gainer, Vivian S ^c   Cheng, Su Chun ^d   Cai, Tianxi ^d   Scoville, Elizabeth ^a   Konijeti, Gauree G ^a   Szolovits, Peter ^e   Shaw, Stanley Y ^a,b   Churchill, Susanne ^f   Karlson, Elizabeth W ^b,f   Murphy, Shawn N ^a,b,c   Kohane, Isaac ^b,f,g   Liao, Katherine P ^b,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PARTNERS HEALTHCARE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

CD; Clot; UC; Vascular; Vein

Indexed keywords

CORTICOSTEROID; DALTEPARIN; ENOXAPARIN; HEMOGLOBIN; HEPARIN; SERUM ALBUMIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DEEP VEIN THROMBOSIS; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; LEUKOCYTE COUNT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT OUTCOME; ULCERATIVE COLITIS; VENOUS THROMBOEMBOLISM; COMPLICATION; INFLAMMATORY BOWEL DISEASE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOEMBOLISM;

EID: 84908229210     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.02.034     Document Type: Article

References (35)

1. Kappelman M.D., Farkas D.K., Long M.D., et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol 2014, 12:265-273.
2. Nguyen G.C., Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:2272-2280.
3. Novacek G., Weltermann A., Sobala A., et al. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010, 139:779-787.
4. Bernstein C.N., Blanchard J.F., Houston D.S., et al. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001, 85:430-434.
5. Grainge M.J., West J., Card T.R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010, 375:657-663.
6. Murthy S.K., Nguyen G.C. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol 2011, 106:713-718.
7. Koutroumpakis E.I., Tsiolakidou G., Koutroubakis I.E. Risk of venous thromboembolism in patients with inflammatory bowel disease. Semin Thromb Hemost 2013, 39:461-468.
8. Bryant R.V., Jairath V., Curry N., et al. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?. J Crohns Colitis 2014, 8:166-171.
9. Ra G., Thanabalan R., Ratneswaran S., et al. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients. J Crohns Colitis 2013, 7:e479-e485.
10. Tinsley A., Naymagon S., Enomoto L.M., et al. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center. J Crohns Colitis 2013, 7:e635-e640.
11. Falck-Ytter Y., Francis C.W., Johanson N.A., et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed-American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141:e278S-e325S.
12. Fanikos J., Rao A., Seger A.C., et al. Venous thromboembolism prophylaxis for medical service: mostly cancer-patients at hospital discharge. Am J Med 2011, 124:1143-1150.
13. Nguyen G.C., Sharma S. Feasibility of venous thromboembolism prophylaxis during inflammatory bowel disease flares in the outpatient setting: a decision analysis. Inflamm Bowel Dis 2013, 19:2182-2189.
14. Ananthakrishnan A.N., Cagan A., Gainer V.S., et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis 2013, 19:1921-1927.
15. Ananthakrishnan A.N., Cai T., Savova G., et al. Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach. Inflamm Bowel Dis 2013, 19:1411-1420.
16. Liao K.P., Diogo D., Cui J., et al. Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls. Ann Rheum Dis 2013 May 28, Epub ahead of print.
17. Ananthakrishnan A.N., Gainer V.S., Perez R.G., et al. Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther 2013, 37:445-454.
18. Savova G.K., Masanz J.J., Ogren P.V., et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. JAm Med Inform Assoc 2010, 17:507-513.
19. Lawrenson R., Todd J.C., Leydon G.M., et al. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000, 49:591-596.
20. Tamariz L., Harkins T., Nair V. Asystematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiol Drug Saf 2012, 21(Suppl 1):154-162.
21. Charlson M.E., Pompei P., Ales K.L., et al. Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. JChronic Dis 1987, 40:373-383.
22. Papa A., Danese S., Grillo A., et al. Review article: inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003, 98:1247-1251.
23. Spina L., Saibeni S., Battaglioli T., et al. Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia. Am J Gastroenterol 2005, 100:2036-2041.
24. Johannesdottir S.A., Horvath-Puho E., Dekkers O.M., et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 2013, 173:743-752.
25. Stuijver D.J., Majoor C.J., van Zaane B., et al. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest 2013, 143:1337-1342.
26. Ismail G., Mircescu G., Ditoiu A.V., et al. Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters. Int Urol Nephrol 2013 Sep 29, Epub ahead of print.
27. Walsh K.A., Lewis D.A., Clifford T.M., et al. Risk factors for venous thromboembolism in patients with chronic liver disease. Ann Pharmacother 2013, 47:333-339.
28. Folsom A.R., Lutsey P.L., Heckbert S.R., et al. Serum albumin and risk of venous thromboembolism. Thromb Haemost 2010, 104:100-104.
29. Tinsley A., Naymagon S., Trindade A.J., et al. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol 2013, 47:e1-e6.
30. Ang Y.S., Mahmud N., White B., et al. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther 2000, 14:1015-1022.
31. Folwaczny C., Wiebecke B., Loeschke K. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 1999, 94:1551-1555.
32. Davenport D.L., Vargas H.D., Kasten M.W., et al. Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection. Clin Appl Thromb Hemost 2012, 18:569-575.
33. Vandlac A.A., Cowan N.G., Chen Y., et al. Timing, incidence, and risk factors of venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacologic prophylaxis. J Urol 2014, 191:943-947.
34. Huo M.H., Muntz J. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Clin Ther 2009, 31:1129-1141.
35. Nguyen G.C., Wu H., Gulamhusein A., et al. The utility of screening for asymptomatic lower extremity deep venous thrombosis during inflammatory bowel disease flares: a pilot study. Inflamm Bowel Dis 2013, 19:1053-1058.